239 related articles for article (PubMed ID: 29980994)
1. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.
Zhou T; Guan H; Yao J; Xiong X; Ma A
Qual Life Res; 2018 Nov; 27(11):2799-2814. PubMed ID: 29980994
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China.
Deng X; Dong P; Zhang L; Tian D; Zhang L; Zhang W; Li L; Deng J; Ning P; Hu G
BMJ Open; 2017 Sep; 7(9):e015880. PubMed ID: 28871016
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of EQ-5D-3L health utility scores using five country-specific tariffs in a rural population aged 45-69 years in Hua county, Henan province, China.
Wang H; Cao C; Guo C; He Y; Li F; Xu R; Liu M; Liu Z; Pan Y; Liu F; Liu Y; Li J; Cai H; He Z; Ke Y
Health Qual Life Outcomes; 2020 Jul; 18(1):228. PubMed ID: 32660494
[TBL] [Abstract][Full Text] [Related]
4. Assessing Health-Related Quality of Life of Chinese Adults in Heilongjiang Using EQ-5D-3L.
Huang W; Yu H; Liu C; Liu G; Wu Q; Zhou J; Zhang X; Zhao X; Shi L; Xu X
Int J Environ Res Public Health; 2017 Feb; 14(3):. PubMed ID: 28241507
[TBL] [Abstract][Full Text] [Related]
5. Population norms for the EQ-5D-3L in China derived from the 2013 National Health Services Survey.
Yao Q; Liu C; Zhang Y; Xu L
J Glob Health; 2021 Feb; 11():08001. PubMed ID: 33692898
[TBL] [Abstract][Full Text] [Related]
6. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
[TBL] [Abstract][Full Text] [Related]
7. Catalog of EQ-5D-3L Health-Related Quality-of-Life Scores for 199 Chronic Conditions and Health Risks in Denmark.
Hvidberg MF; Petersen KD; Davidsen M; Witt Udsen F; Frølich A; Ehlers L; Alava MH
MDM Policy Pract; 2023; 8(1):23814683231159023. PubMed ID: 37056295
[TBL] [Abstract][Full Text] [Related]
8. Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.
Zhou T; Guan H; Wang L; Zhang Y; Rui M; Ma A
Front Public Health; 2021; 9():675523. PubMed ID: 34268287
[No Abstract] [Full Text] [Related]
9. A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review.
Van Wilder L; Rammant E; Clays E; Devleesschauwer B; Pauwels N; De Smedt D
Qual Life Res; 2019 Dec; 28(12):3153-3161. PubMed ID: 31531840
[TBL] [Abstract][Full Text] [Related]
10. How the EQ-5D utilities are derived matters in Chinese diabetes patients: a comparison based on different EQ-5D scoring functions for China.
Pan CW; Zhang RY; Luo N; He JY; Liu RJ; Ying XH; Wang P
Qual Life Res; 2020 Nov; 29(11):3087-3094. PubMed ID: 32533422
[TBL] [Abstract][Full Text] [Related]
11. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran.
Zare F; Ameri H; Madadizadeh F; Aghaei MR
Diabetes Metab Syndr; 2021; 15(1):319-324. PubMed ID: 33486224
[TBL] [Abstract][Full Text] [Related]
12. Assessing the reliability and validity of the ICECAP-A instrument in Chinese type 2 diabetes patients.
Xiong Y; Wu H; Xu J
Health Qual Life Outcomes; 2021 Jan; 19(1):5. PubMed ID: 33407525
[TBL] [Abstract][Full Text] [Related]
13. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China.
Sun S; Chen J; Kind P; Xu L; Zhang Y; Burström K
Qual Life Res; 2015 Mar; 24(3):693-703. PubMed ID: 25246184
[TBL] [Abstract][Full Text] [Related]
14. Does the magnitude of injuries affect the outcome of proximal humerus fractures treated by locked plating (PHILOS)?
Berk T; Halvachizadeh S; Bellmann F; Büsser L; Pape HC; Allemann F
Eur J Trauma Emerg Surg; 2022 Dec; 48(6):4515-4522. PubMed ID: 32778927
[TBL] [Abstract][Full Text] [Related]
15. Population health status based on the EQ-5D-Y-3L among adolescents in Sweden: Results by sociodemographic factors and self-reported comorbidity.
Åström M; Persson C; Lindén-Boström M; Rolfson O; Burström K
Qual Life Res; 2018 Nov; 27(11):2859-2871. PubMed ID: 30196340
[TBL] [Abstract][Full Text] [Related]
16. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
Bae E; Choi SE; Lee H; Shin G; Kang D
BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387
[TBL] [Abstract][Full Text] [Related]
17. Validity and reliability of EQ-5D-3L for breast cancer patients in Korea.
Kim SH; Jo MW; Lee JW; Lee HJ; Kim JK
Health Qual Life Outcomes; 2015 Dec; 13():203. PubMed ID: 26694964
[TBL] [Abstract][Full Text] [Related]
18. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.
Jiang J; Hong Y; Zhang T; Yang Z; Lin T; Liang Z; Lu P; Liu L; Wang B; Xu Y; Luo N
Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418
[TBL] [Abstract][Full Text] [Related]
19. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
20. Catalogues of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks for Use in the UK and the USA.
Falk Hvidberg M; Hernández Alava M
Pharmacoeconomics; 2023 Oct; 41(10):1287-1388. PubMed ID: 37330973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
